TY  - GEN
AU  - Roberts,Reade B
AU  - Arteaga,Carlos L
AU  - Threadgill,David W
TI  - Modeling the cancer patient with genetically engineered mice: prediction of toxicity from molecule-targeted therapies
SN  - 1535-6108
PY  - 2004///0517
KW  - Animals
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents
KW  - Benzamides
KW  - Cardiomyoplasty
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Cyclooxygenase 2
KW  - Disease Models, Animal
KW  - ErbB Receptors
KW  - antagonists & inhibitors
KW  - Gastrointestinal Diseases
KW  - chemically induced
KW  - Genes, abl
KW  - physiology
KW  - Genetic Engineering
KW  - Humans
KW  - Imatinib Mesylate
KW  - Isoenzymes
KW  - Membrane Proteins
KW  - Mice
KW  - Mice, Transgenic
KW  - genetics
KW  - Neoplasms
KW  - Piperazines
KW  - Prostaglandin-Endoperoxide Synthases
KW  - metabolism
KW  - Pyrimidines
KW  - Receptors, Platelet-Derived Growth Factor
KW  - Receptors, Transforming Growth Factor beta
KW  - Skin Abnormalities
KW  - Trastuzumab
KW  - Vascular Endothelial Growth Factor A
N1  - Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review
UR  - https://doi.org/10.1016/s1535-6108(04)00032-7
ER  -